MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Moxibustion for Parkinson’s disease: a systematic review of randomized controlled trials

T.-H. Kim, S. Kwon, W.-S. Jung, S.-K. Moon, C.-N. Ko, S.-Y. Cho, C.-Y. Jun, S.-H. Lee, K.-H. Cho (Seoul, Republic of Korea)

Meeting: 2017 International Congress

Abstract Number: 1411

Keywords: Motor control

Session Information

Date: Thursday, June 8, 2017

Session Title: Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: This systematic review aimed to evaluate effectiveness and safety of moxibustion therapy for IPD patients.

Background: Idiopathic Parkinson’s disease (IPD) is a chronic neurodegenerative disorder which requires medical care for many years after the first diagnosis. Moxibustion, burning of Mugwort or Moxa for stimulating acupuncture point on the skin, is one of the common non-drug treatments for IPD in traditional East-Asian medicine. Currently there is no systematic reviews on the effect of moxibustion for IPD.

Methods: Electronic databases including Medline, the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, OASIS (Korean database), CNKI (Chinese database) were searched until December, 2016. Search strategy were modified based on the individual databases but mainly 2 words, “Parkinson’s disease” and “Moxibustion” were combined appropriately for database search. Data extraction and risk of bias were assessed by two researchers (KTH and KSW) and an arbiter (CKH) decided disagreement between researchers. Risk ratio (RR) was used for the effect estimates for dichotomous outcomes and mean difference (MD) was for continuous outcomes in meta-analysis. Fixed effect model was planned to use for meta-analysis but random effect model was adopted if statistical heterogeneity was observed.

Results: A total of 10 studies (644 IPD patients) were included in this review (figure 1). Overall methodological rigor could not be ensured because detailed information was not suggested in most of the studies (figure 2). Comparing with moxibustion group and control group, there was no significant difference in the overall effectiveness ratio (RR 1.20, 95% CI [1.00 to 1.44], figure 3). About total UPDRS score, there was no significant difference between moxibustion and control interventions (MD -6.75, 95% CI [-14.4 to 0.92]) regardless of moxibustion type (direct moxibustion: MD -9.53 95% CI [-19.45 to 0.40] / Moxa stick: MD -3.65, 95% CI [-21.26 to 13.96], figure 4).  Adverse events related to moxibustion treatment were not reported in most of the studies.

Conclusions: Conclusive evidence on the benefit and harm of moxibustion therapy for IPD could not be suggested due to methodological problems and clinical heterogeneity among the included studies. More rigorous clinical studies will be necessary in future.

References: 1. Chen X. Clinical Observation on 30 Cases of Paralysis Agitans Treated by Acupuncture plus Direct Moxibustion. Journal of Traditional Chinese Medicine 1999;40(06):342-43.

2. Deng X. Clinical Observation on Moxibustion in the treatment of Myotonicmyopathies of Parkinson’s Disease. Guangzhou University of Chinese Medicine, 2010.

3. Hu B, Xu Y. Clinical Observation of Acupuncture Combined with Moxibustion in Treating Sleep Disorders of Parkinson ‘s Disease. World Federation of Chinese Medicine Societies Professional Committee of the establishment of the General Assembly of Chinese Medicine Symposium of Chinese Medicine Symposium General Assembly 2013 annual meeting of conference proceedings 2013

4. Jun L. Mild moxibustion with Madopar in Parkinson’s patients to improve the clinical observation of daily activities. Hubei University of Chinese Medicine, 2011.

5. Li M, Zheng J, Wang H, et al. Effect of acupuncture and moxibustion combined with Deanxit in the treatment of neuropsychiatric disorders of Parkinson’s disease. Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine 2016(06):68-69, 83.

6. WEN X, LI Yw, DUAN Q. Abdominal Acupuncture plus Moxibustion for Treatment of Parkinson Disease Rigidity in 30 Patients. Academic Journal of Guangzhou Medical College 2008;36(01):59-61.

7. Zhang J, Sun G, Zhao G. Observation on therapeutic effect of herbs-partitioned moxibustion on Parkinson disease of 54 cases. Zhongguo zhen jiu = Chinese acupuncture & moxibustion 2005;25(9):610-12.

8. Zhang P. Clinical study on abdominal-acupuncture binding moxibustion in the treatment of Parkinson’s disease. Guangzhou University of Chinese Medicine, 2008.

9. Zhang J-m, HU D, XU L. Observations on the Efficacy of Heavy Moxibustion on Pont Yongquan as Main Treatment for Parkinson’s Disease. Shanghai Journal of Acupuncture and Moxibustion 2012(11)

10. Zhao Y, Liu P, Wang M, et al. Clinical Observation of Needle Warming Moxibustion Combined with Function Training on Dysphagia of Parkinson’s disease. Chinese Medicine Modern Distance Education of China 2015(07):61-63.

To cite this abstract in AMA style:

T.-H. Kim, S. Kwon, W.-S. Jung, S.-K. Moon, C.-N. Ko, S.-Y. Cho, C.-Y. Jun, S.-H. Lee, K.-H. Cho. Moxibustion for Parkinson’s disease: a systematic review of randomized controlled trials [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/moxibustion-for-parkinsons-disease-a-systematic-review-of-randomized-controlled-trials/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/moxibustion-for-parkinsons-disease-a-systematic-review-of-randomized-controlled-trials/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley